FDA OKs Apremilast (Otezla) for Oral Ulcers of Behcet ' s Disease FDA OKs Apremilast (Otezla) for Oral Ulcers of Behcet ' s Disease

The oral phosphodiesterase-4 inhibitor is the first FDA approval for this indication.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news